IP Library Granted Patent US 11,015,181
Granted Patent B2
US 11,015,181 · App. 16/105,930 · Granted May 25, 2021

Nucleic acids useful for integrating into and gene expression in hyperthermophilic acidophilic Archaea

Inventors: Steven M. Yannone (Concord, CA); Adam Barnebey (Berkeley, CA)
Assignee: The Regents of the University of California
C12N9/2437C12N15/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,015,181
App. No.
16/105,930
Granted
May 25, 2021
Kind
B2
Abstract

The present invention provides for a novel recombinant or isolated nucleic acid useful for integrating or being maintained in an Archaea or acidophilic hyperthermophilic eubacteria. The nucleic acid encodes a nucleotide sequence that is capable of stably integrating into the chromosome of a host cell, or being maintained as an extrachromosomal element in a host cell, that is an Archea, and a nucleotide sequence of interest. The present invention also provides for an Archaea host cell comprising the nucleic acid stably integrated into the chromosome or maintained episomally in the host cell, and a method of expressing the nucleotide sequence of interest in the host cell and/or directing glycosylation, multimerization, and/or membrane association or integration.

Claims (15)

1. A recombinant or isolated nucleic acid comprising: (a) a nucleotide sequence comprising a Fusellovirus integration sequence that integrates into a Sulfolobus species chromosome; and (b) a nucleotide sequence of interest, wherein the nucleotide sequence of interest is operably linked to a minimal promoter and encodes a protein that is biologically activate at a temperature equal to or more than about 70° C. and/or a pH equal to or less than about 4.0, wherein the minimal promoter is an AraS to tf55 promoter.

2. The nucleic acid of claim 1 , wherein the Fusellovirus is a Sulfolobus spindle-shaped virus.

3. The nucleic acid of claim 2 , wherein the Sulfolobus spindle-shaped virus is SSV1, SSV2, SSV3, SSVL1, SSVK1, or SSVRH.

4. The nucleic acid of claim 1 , wherein the protein comprises an export peptide signal at the 5′ end.

5. The nucleic acid of claim 1 , wherein the protein needs to be expressed, synthesized and/or folded at a temperature equal to or more than about 70° C., 75° C., 80° C., 85° C., or 90° C. in order to be correctly folded and to be biologically active; and/or needs to be glycosylated during or after expression, synthesis and/or folding in order to be biologically active.

6. The nucleic acid of claim 1 , further comprising one or more control sequences which permit stable maintenance of the nucleic acid as a vector in a non- Sulfolobus host cell.

7. An Archaea host cell comprising the nucleic acid of claim 1 stably integrated into the chromosome of the host cell.

8. The host cell of claim 7 , wherein the host cell is hyperthermophilic or acidophilic.

9. The host cell of claim 7 , wherein the host cell is capable of growth or is viable at a temperature equal to or more than about 70° C., 75° C., 80° C., 85° C., or 90° C.

10. The host cell of claim 7 , wherein the host cell is capable of growth or is viable at a pH equal to or less than about 4.0, 3.5, 3.0, 2.5, or 2.0.

11. The host cell of claim 7 , wherein the Archaea is of the genus Sulfolobus.

12. A method of genetically modifying a host cell comprising: (a) introducing a nucleic acid of claim 1 into a host cell that is an Archea or acidophilic hyperthermophilic eubacteria, and (b) integrating the nucleic acid into the chromosome of the host cell.

13. A method of expressing a protein of interest in an Archaea, comprising: culturing the host cell of claim 7 in a suitable medium such that the protein is expressed, and optionally isolating the protein from the host cell.

14. The method of claim 13 , wherein the protein is a thermophilic enzyme, or enzymatically active fragment thereof, that catalyzes an enzymatic reaction.

15. The method of claim 14 , wherein the protein is a cellulase.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 26, 2019
From: UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 048704/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2018
From: YANNONE, STEVEN M.; BARNEBEY, ADAM
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 047556/0747 →
Continuity (3)
Continuation 14646673
Provisional Application 61729268 · Nov 21, 2012
Related Publication 20180355336A1 · Dec 13, 2018